Menu Close

Alzheimer’s and Parkinson’s biomarkers show promise for early diagnosis

New research supported by the Knight Initiative for Brain Resilience at Stanford’s Wu Tsai Neurosciences Institute highlights significant strides researchers have made in developing biomarkers for the early detection and monitoring of neurodegenerative diseases—including Alzheimer’s disease (AD), Parkinson’s disease (PD) and Lewy body disease (LBD).